Research Associate
Laboratory for Molecular Biomedicine

Institute of Molecular Genetics and Genetic Engineering (IMGGE),
University of Belgrade (UB)

Vojvode Stepe 444a, PO box 23, 11010 Belgrade, Serbia
Mobile:    +381 65 397 64 45                            
Phone:    +381 11 397 64 45
Fax:        +381 11 397 58 08
E-mail: biljana.stankovic@imgge.bg.ac.rs                 

EDUCATION

2015 - PhD in Molecular Biology, Faculty of Biology (FB), University of Belgrade (UB) (Thesis: „Molecular markers of chronic inflammation and apoptosis in inflammatory bowel diseases“)
2009 - Diploma (equivalent to M.Sc.) in Molecular biology and physiology, FB, UB

RESEARCH EXPERIENCE

2016 - Research Associate at Laboratory for Molecular Biomedicine, IMGGE
2011 - Research Assistant at Laboratory for Molecular Biomedicine, IMGGE
2010 - Research Trainee at Laboratory for Molecular Hematology, IMGGE

RESEARCH INTEREST

The focus of my research is identification of molecular markers associated with chronic inflammatory bowel diseases (CIBD), among which are Crohn’s disease (ChD), ulcerative colitis (UC) and celiac disease (CD). Candidate genes for disease risk assessment are the ones that alter regulation of inflammatory and apoptotic processes. Analysis of patients’ genetic and expression profiles will provide better understanding of CIBD pathogenesis and enable discovering of novel disease markers. My research interest is also directed to pharmacogenetics of ChD and UC, as well as to analysis of newly synthetized small molecules that could be potential therapeutics of these two diseases.

SELECTED PUBLICATIONS

[1]  Balasopoulou A, Stanković B, Panagiotara A, Nikčevic G, Peters BA, John A, Mendrinou E, Stratopoulos A, Legaki AI, Stathakopoulou V, Tsolia A, Govaris N, Govari S, Zagoriti Z, Poulas K, Kanariou M, Constantinidou N, Krini M, Spanou K, Radlovic N, Ali BR, Borg J, Drmanac R, Chrousos G, Pavlovic S, Roma E, Zukic B, Patrinos GP, Katsila T. Novel genetic risk variants for pediatric celiac disease. Hum Genomics. 2016 Oct 24; 10(1):34.

https://www.ncbi.nlm.nih.gov/pubmed/27836013

[2] Stankovic B, Dragasevic S, Popovic D, Zukic B, Kotur N, Sokic-Milutinovic A, Alempijevic T, Lukic S, Milosavljevic T, Nikcevic G, Pavlovic S.  Variations in inflammatory genes as molecular markers for prediction of inflammatory bowel disease occurrence. J Dig Dis. 2015 Dec; 16(12):723-33.

https://www.ncbi.nlm.nih.gov/pubmed/26316104

[3] Stanković B, Radlović N, Leković Z, Ristić D, Radlović V, Nikčević G, Kotur N, Vučićević K, Kostić T, Pavlović S, Zukic B. HLA genotyping in pediatric celiac disease patients. Bosn J Basic Med Sci. 2014 Aug 16; 14(3):171-6.

http://www.ncbi.nlm.nih.gov/pubmed/25172978

[4] Kotur N, Dokmanovic L, Janic D, Stankovic B, Krstovski N, Tosic N, Katsila T, Patrinos GP, Zukic B, Pavlovic S. TPMT gene expression is increased during maintenance therapy in childhood acute lymphoblastic leukemia patients in a TPMT gene promoter variable number of tandem repeat-dependent manner. Pharmacogenomics. 2015; 16(15):1701-12.

https://www.ncbi.nlm.nih.gov/pubmed/26411491

[5] Kotur N, Stankovic B, Kassela K, Georgitsi M, Vicha A, Leontari I, Dokmanovic L, Janic D, Krstovski N, Klaassen K, Radmilovic M, Stojiljkovic M, Nikcevic G, Simeonidis A, Sivolapenko G, Pavlovic S, Patrinos GP, Zukic B. 6-mercaptopurine influences TPMT gene transcription in a TPMT gene promoter variable number of tandem repeats-dependent manner. Pharmacogenomics. 2012; 13(3): 283-95.

https://www.ncbi.nlm.nih.gov/pubmed/22304581

[6] Klaassen K, Stankovic B, Kotur N, Djordjevic M, Zukic B, Nikcevic G, Ugrin M, Spasovski V, Srzentic S, Pavlovic S, Stojiljkovic M. New PAH gene promoter KLF1 and 3'-region C/EBPalpha motifs influence transcription in vitro. J Appl Genet. 2016 Jul 22.

https://www.ncbi.nlm.nih.gov/pubmed/27447460

[7] Obradović J, Djordjević N, Tošic N, Mrdjanović J, Stanković B, Stanić J, Zarić B, Perin B, Pavlović S, Jurišić V. Frequencies of EGFR single nucleotide polymorphisms in non-small cell lung cancer patients and healthy individuals in the Republic of Serbia: a preliminary study. Tumour Biol. 2016 Aug; 37(8):10479-86.

https://www.ncbi.nlm.nih.gov/pubmed/26846215

[8]  Alimpic A, Kotur N, Stanković B, Marin P, Matevski V, Al Sheef N, Duletić-Laušević S. The in vitro antioxidative and cytotoxic effects of selected Salvia species water extracts. Journal Of Applied Botany And Food Quality 2015; 88(1).

[9] Radmilovic M, Zukic B, Petrovic MS, Bartsakoulia M, Stankovic B, Kotur N, Dokmanovic L, Georgitsi M, Patrinos GP, Pavlovic S. Functional analysis of a novel KLF1 gene promoter variation associated with hereditary persistence of fetal hemoglobin. Ann Hematol. 2013 Jan; 92(1):53-8.

https://www.ncbi.nlm.nih.gov/pubmed/23161389

[10] Srzentić S, Spasovski V, Spasovski D, Zivković Z, Matanović D, Bascarević Z, Supić ZT, Stojiljković M, Karan-Djurasević T, Stanković B, Pavlović S, Nikcević G, Vukasinović Z. Association of gene variants in TLR4 and IL-6 genes with Perthes disease. Srp Arh Celok Lek. 2014 Jul-Aug; 142(7-8):450-6.

http://www.ncbi.nlm.nih.gov/pubmed/25233690

[11] Jančić I, Arsenović-Ranin N, Sefik-Bukilica M, Zivojinović S, Damjanov N, Spasovski V, Srzentić S, Stanković B, Pavlović S. -174G/C interleukin-6 gene promoter polymorphism predicts therapeutic response to etanercept in rheumatoid arthritis. Rheumatology International 2013; 33(6): 1481-6.

http://www.ncbi.nlm.nih.gov/pubmed/23233117

[12] Radmilovic M, Zukic B, Petrovic MS, Bartsakoulia M, Stankovic B, Kotur N, Dokmanovic L, Georgitsi M, Patrinos GP, Pavlovic S. Functional analysis of a novel KLF1 gene promoter variation associated with hereditary persistence of fetal hemoglobin. Annals of Hematology 2013; 92(1): 53-8.

http://www.ncbi.nlm.nih.gov/pubmed/23161389

[13] Radmilovic M, Zukic B, Stankovic B, Karan-Djurasevic T, Stojiljkovic M, Spasovski V, Tosic N, Dokmanovic L, Janic D, Pavlovic S. Thalassemia Syndromes in Serbia: An update. Hemoglobin 2010; 34 (5): 477-85.

http://www.ncbi.nlm.nih.gov/pubmed/20854122